Annexon Bioscience Receives $34,000,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=babe42c9-231a-4b3b-873a-30a90ccade03
Date
12/16/2014
Company Name
Annexon Bioscience
Mailing Address
Undisclosed Redwood City, CA 94062 USA
Company Description
Annexon is developing novel therapeutics for neurodegenerative and autoimmune disorders. We have discovered that early components of the classical complement cascade accumulate on synapses with normal aging and are activated as the brain encounters stress or disease to cause loss of nerve connections.
Website
http://www.annexonbio.com
Transaction Type
Venture Equity
Transaction Amount
$34,000,000
Transaction Round
Series A
Proceeds Purposes
The company intends to use the funds for the development of its lead candidate, ANX005, for the treatment of neurodegenerative and autoimmune disorders.
M&A Terms
Venture Investor
Venture Investor
Venture Investor